Original Research
Accepted on 30 Nov 2025
Safety and Efficacy of B cell Therapy in Older People with Mul:ple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 386 views
Type at least 3 characters
1,480 articles
articles
Correction
Accepted on 28 Nov 2025
Correction: Morphometric MRI findings in patients with suspected autoimmune psychosis spectrum syndromes and association with EEG slowing, CSF changes, and psychometric/neuropsychological findings
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
Correction
Accepted on 27 Nov 2025
Correction: Morphometric MRI findings in patients with suspected autoimmune psychosis spectrum syndromes and association with EEG slowing, CSF changes, and psychometric/neuropsychological findings
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
- 165 views
Original Research
Published on 21 Nov 2025
Modeling lymphocyte subset dynamics after ublituximab therapy in patients with multiple sclerosis: an Italian prospective study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1688090
- 1,441 views
Review
Published on 20 Nov 2025
The critical role of Th17 cells and IL-17A in autoimmune and inflammation-associated neurological diseases: mechanisms and therapeutic perspectives
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1656422
- 1,395 views
Mini Review
Published on 20 Nov 2025
Neuroimmune modulatory effects of the NLRP3 inflammasome: the role of sex and living environment in brain affecting conditions
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1711656
- 1,233 views
Correction
Published on 20 Nov 2025
Correction: Polysialic acid restrains inflammatory monocyte maturation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1731973
- 580 views
Review
Published on 20 Nov 2025
Decoding tRNA dynamics in neuroimmune disorders: mechanistic insights, diagnostic innovations, and therapeutic opportunities
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1642370
- 1,018 views
Review
Published on 19 Nov 2025
Vaccination and COVID-19: impact on long-COVID
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1686572
- 1,918 views
Original Research
Published on 19 Nov 2025
Natalizumab and fumarate treatment differentially modulate CD4+ T cell and B cell subtypes in multiple sclerosis patients without impacting durable COVID-19 vaccine responses
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1568157
- 1,316 views
Original Research
Published on 11 Nov 2025
Genetic knockdown of DYRK1A attenuates cognitive impairment, Aβ pathology, tauopathy and neuroinflammatory responses in mouse models of AD
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1661791
- 1,645 views
Original Research
Published on 07 Nov 2025
Prognostic value of kappa free light chain index in patients with primary progressive multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1658182
- 1,709 views
Original Research
Published on 04 Nov 2025
Sex differences in abnormal gluten response and predictors of gluten sensitivity in patients with schizophrenia
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1696763
- 927 views
Review
Published on 30 Oct 2025
The mechanisms of specialized pro-resolving mediators in pain relief: neuro-immune and neuroglial regulations
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1634724
- 1,938 views
- 1 citation
Original Research
Published on 29 Oct 2025
Antibodies to myelin oligodendrocyte glycoprotein in optic perineuritis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1657600
- 1,055 views
Original Research
Published on 28 Oct 2025
Intestinal mucosal alterations parallel central demyelination and remyelination: insights into the gut-brain axis in the cuprizone model of multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1682183
- 2,180 views
Brief Research Report
Published on 27 Oct 2025
Combination therapy of ofatumumab and daratumumab in patients with severe anti-NMDA receptor encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1681884
- 1,280 views
Original Research
Published on 27 Oct 2025
The ATP-mediated cytokine release by macrophages is down-modulated by unconventional α9* nicotinic acetylcholine receptors
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1661114
- 1,617 views
Original Research
Published on 27 Oct 2025
The diagnostic and prognostic value of CXCL13, CXCL10, and CXCL8 in patients with neurosyphilis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1654251
- 1,271 views
Original Research
Published on 22 Oct 2025
Global, regional, and national trends and burden of multiple sclerosis in adolescents and young adults: a data analysis from 1990 to 2021 and projections to 2040
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1685316
- 1,754 views
Study Protocol
Published on 22 Oct 2025
The efficacy, safety, and pharmacokinetics/pharmacodynamics of telitacicept following efgartigimod in generalized myasthenia gravis: protocol of a randomized controlled trial
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1604786
- 2,443 views
Original Research
Published on 20 Oct 2025
Polysialic acid restrains inflammatory monocyte maturation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1656087
- 1,822 views
Original Research
Published on 20 Oct 2025
Neutrophils from Alzheimer’s disease mice fail to phagocytose debris and show altered release of immune modulators with age
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1672768
- 2,398 views
Original Research
Published on 20 Oct 2025
Immune checkpoint-based biomarkers for therapeutic response in patients with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1694021
- 1,885 views